A.R.T. Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-66,936
Closed -$1.28M – 1589
2019
Q3
$1.28M Buy
66,936
+45,600
+214% +$1.07M 0.06% 435
2019
Q2
$468K Buy
+21,336
New +$468K 0.03% 767
2019
Q1
– Sell
-21,036
Closed -$265K – 1510
2018
Q4
$265K Sell
21,036
-14,386
-41% -$214K 0.02% 971
2018
Q3
$543K Buy
+35,422
New +$490K 0.02% 823
2017
Q2
– Sell
-13,300
Closed -$104K – 1614
2017
Q1
$104K Buy
+13,300
New +$108K ﹤0.01% 1261
2016
Q3
– Sell
-49,185
Closed -$395K – 984
2016
Q2
$395K Buy
49,185
+19,000
+63% +$152K 0.02% 877
2016
Q1
$203K Buy
+30,185
New +$199K 0.01% 1164
2014
Q4
– Sell
-53,807
Closed -$280K – 1572
2014
Q3
$280K Buy
+53,807
New +$276K 0.01% 965
2013
Q4
– Sell
-14,981
Closed -$44K – 1426
2013
Q3
$44K Buy
+14,981
New +$42.2K ﹤0.01% 1260

Other funds holding NEO

A.R.T. Advisors's NEO Position: Q4 2019 in Review

A.R.T. Advisors sold out of NeoGenomics (NEO) in Q4 2019, closing a stake of 66,936 shares — an estimated $1.28M sold.

A.R.T. Advisors first reported a position in NEO in Q3 2013 and held it in 9 quarters. The position peaked at $1.28M in Q3 2019. 261 funds tracked by Wall St. Rank hold NEO as of Q4 2019.

  • A.R.T. Advisors reported no remaining NeoGenomics position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 66,936 NeoGenomics shares in Q4 2019, an estimated $1.28M.
  • A.R.T. Advisors first reported a position in NeoGenomics in Q3 2013 and held it in 9 quarters.
  • A.R.T. Advisors's NeoGenomics position peaked at $1.28M in Q3 2019.
  • 261 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.